|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable - related party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accounts receivable - related party | ||||||||||||||||||||
| Marketable securities, trading | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Notes receivable - related party - current portion | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total notes receivable - related party - current portion | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Fixed Assets, Net | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Notes receivable - related party, net of current portion and discount of $5,610 and $7,214 at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Interest receivable - related party | ||||||||||||||||||||
| Trade receivable, net of discount of $12,927 and $14,639 at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Total Other Assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Deferred revenue - related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Due to officers or stockholders, current | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| $0.0001 par value; 50,000,000 shares authorized; 15,899,483 issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
Loading...
